4 February 2016 - Deborah Wilkes
Archived
GlaxoSmithKline does not intend to spin off its Consumer Healthcare business in the near future, according to chief executive officer Sir Andrew Witty, but might consider the option in a few years.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.